Viewing StudyNCT05577715



Ignite Creation Date: 2024-05-06 @ 6:10 PM
Last Modification Date: 2024-10-26 @ 2:43 PM
Study NCT ID: NCT05577715
Status: RECRUITING
Last Update Posted: 2023-07-18
First Post: 2022-10-10

Brief Title: A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer NSCLC Adenocarcinoma AC
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Conditions & Keywords Data

Conditions:
Name
Carcinoma Non-Small-Cell Lung
Keywords:
Name View
NSCLC View
MORAb-202 View
Farletuzumab ecteribulin View
Adenocarcinoma View